Literature DB >> 4049534

Early detection of breast cancer recurrences through periodic follow-up--is it useless?

S Ciatto, M Rosselli Del Turco, P Pacini, G Mustacchi, M Simonis, P Sismondi, G Giardina, V Belsanti, C Aristei, A M Molino.   

Abstract

The authors report on a multicentric consecutive series of 1120 breast cancer first recurrences. Cases detected as subjectively asymptomatic thanks to periodic follow-up examinations are compared to cases detected as symptomatic. The relapse-free interval from primary treatment was shorter for asymptomatic recurrences, confirming that an earlier diagnosis was achieved in these cases. In spite of this diagnostic anticipation, median and actuarial survival from primary treatment did not differ when asymptomatic recurrences were compared to symptomatic recurrences. The study results did not show any prognostic impact of periodic follow-up in breast cancer and urge for prospective controlled studies on this diffuse and expensive practice.

Entities:  

Mesh:

Year:  1985        PMID: 4049534     DOI: 10.1177/030089168507100402

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  Prolonged survival by 'early' salvage treatment of breast cancer patients: a retrospective 6-year study.

Authors:  A Nicolini; L Anselmi; C Michelassi; A Carpi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

2.  Chest X-ray survey in the follow-up of breast cancer patients.

Authors:  S Ciatto; P Pacini; C Andreoli; S Cecchini; A Iossa; G Grazzini; F Buranelli; T Campa; A Costa; A Magni
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

3.  The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.

Authors:  M Gion; R Mione; O Nascimben; M Valsecchi; C Gatti; A Leon; G Bruscagnin
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

4.  Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA.

Authors:  M Gion; M Plebani; R Mione; C Penzo; S Meo; A Burlina
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.